Kan Yonemori

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 355 publications

JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan.

JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan.

Journal: ESMO real world data and digital oncology

Published: August 08, 2026

Integrating DNA Mutations and RNA Expression of Cancer Driver Genes in Asian Rare Cancers: A Pan-Cancer Analysis.

Integrating DNA Mutations and RNA Expression of Cancer Driver Genes in Asian Rare Cancers: A Pan-Cancer Analysis.

Journal: JCO precision oncology

Published: June 29, 2026

Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial.

Patient-reported outcomes with tisotumab vedotin versus chemotherapy in patients with recurrent or metastatic cervical cancer: post hoc analyses from the open-label, randomized, phase 3 ENGOT-cx12/GOG-3057/innovaTV 301 trial.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: May 19, 2026

Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design).

Phase II basket study of brigatinib for ALK fusion-positive solid tumors: WJOG15221M/ALLBREAK (a decentralized clinical trial design).

Journal: Future oncology (London, England)

Published: April 15, 2026

Dose intensity and clinical outcomes across age groups in high-grade osteosarcoma treated with methotrexate, adriamycin, and cisplatin therapy.

Dose intensity and clinical outcomes across age groups in high-grade osteosarcoma treated with methotrexate, adriamycin, and cisplatin therapy.

Journal: Japanese journal of clinical oncology

Published: March 26, 2026

Cooccurrence of myelodysplastic neoplasm and myeloid sarcoma with background mediastinal germ cell tumor: an autopsy case.

Cooccurrence of myelodysplastic neoplasm and myeloid sarcoma with background mediastinal germ cell tumor: an autopsy case.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 01, 2026

Impact of travel costs on disparities in precision oncology clinical trials.

Impact of travel costs on disparities in precision oncology clinical trials.

Journal: ESMO real world data and digital oncology

Published: February 06, 2026

Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer.

Clinical implications of discordance in HER2 reassessment from HercepTest to 4B5 in metastatic breast cancer.

Journal: Breast cancer research and treatment

Published: January 23, 2026

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.

Lenvatinib plus pembrolizumab in previously treated advanced endometrial cancer: 5-year outcomes from the randomized, phase 3 Study 309/KEYNOTE-775.

Journal: Journal for immunotherapy of cancer

Published: January 20, 2026

Preclinical Evaluation of Liposomal Eribulin (E7389-LF) in a Panel of Sarcoma Patient-Derived Xenograft Models.

Preclinical Evaluation of Liposomal Eribulin (E7389-LF) in a Panel of Sarcoma Patient-Derived Xenograft Models.

Journal: Molecular cancer therapeutics

Published: January 20, 2026

Phase II study of pembrolizumab plus olaparib in recurrent cervical cancer progressing after platinum-based chemotherapy (GOTIC-025).

Phase II study of pembrolizumab plus olaparib in recurrent cervical cancer progressing after platinum-based chemotherapy (GOTIC-025).

Journal: Gynecologic oncology

Published: January 18, 2026

Cancer genome profiling in sarcomas: current status and future perspectives in Japan.

Cancer genome profiling in sarcomas: current status and future perspectives in Japan.

Journal: Expert review of anticancer therapy

Published: January 16, 2026

Showing 1-12 of 355

Last Updated: 09/26/2026